In both chronic HCV and NAFLD, monocyte CCR2 expression was significantly lower (confirming a previous study [18]) and CCR4 expression was significantly higher compared to control subjects, regardless of disease stage. Here, CCR4 is linked to metabolic dysfunction-associated steatotic liver disease.